These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31144417)
1. Temper outbursts in Lowe syndrome: Characteristics, sequence, environmental context and comparison to Prader-Willi syndrome. Cressey H; Oliver C; Crawford H; Waite J J Appl Res Intellect Disabil; 2019 Sep; 32(5):1216-1227. PubMed ID: 31144417 [TBL] [Abstract][Full Text] [Related]
2. Temper outbursts in Prader-Willi syndrome: causes, behavioural and emotional sequence and responses by carers. Tunnicliffe P; Woodcock K; Bull L; Oliver C; Penhallow J J Intellect Disabil Res; 2014 Feb; 58(2):134-50. PubMed ID: 23374136 [TBL] [Abstract][Full Text] [Related]
3. Sertraline as a treatment option for temper outbursts in Prader-Willi syndrome. Deest M; Jakob MM; Seifert J; Bleich S; Frieling H; Eberlein C Am J Med Genet A; 2021 Mar; 185(3):790-797. PubMed ID: 33369086 [TBL] [Abstract][Full Text] [Related]
4. The characteristics of temper outbursts in Prader-Willi syndrome. Rice LJ; Woodcock K; Einfeld SL Am J Med Genet A; 2018 Nov; 176(11):2292-2300. PubMed ID: 30289600 [TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of monoamine oxidase A promoter/exon 1 region is associated with temper outbursts in Prader-Willi syndrome. Deest M; Buchholz V; Jahn K; Eberlein C; Bleich S; Frieling H J Psychiatr Res; 2022 May; 149():359-366. PubMed ID: 34782122 [TBL] [Abstract][Full Text] [Related]
6. Signalling changes to individuals who show resistance to change can reduce challenging behaviour. Bull LE; Oliver C; Woodcock KA J Behav Ther Exp Psychiatry; 2017 Mar; 54():58-70. PubMed ID: 27367567 [TBL] [Abstract][Full Text] [Related]
7. Associations between repetitive questioning, resistance to change, temper outbursts and anxiety in Prader-Willi and Fragile-X syndromes. Woodcock K; Oliver C; Humphreys G J Intellect Disabil Res; 2009 Mar; 53(3):265-78. PubMed ID: 18771510 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole treatment for temper outbursts in Prader-Willi syndrome. Deest M; Wieting J; Jakob MM; Deest-Gaubatz S; Groh A; Seifert J; Toto S; Bleich S; Frieling H; Eberlein CK Orphanet J Rare Dis; 2022 Aug; 17(1):324. PubMed ID: 36028863 [TBL] [Abstract][Full Text] [Related]
9. The developmental trajectory of disruptive behavior in Down syndrome, fragile X syndrome, Prader-Willi syndrome and Williams syndrome. Rice LJ; Gray KM; Howlin P; Taffe J; Tonge BJ; Einfeld SL Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):182-7. PubMed ID: 25983069 [TBL] [Abstract][Full Text] [Related]
11. Transcutaneous vagus nerve stimulation (t-VNS): A novel effective treatment for temper outbursts in adults with Prader-Willi Syndrome indicated by results from a non-blind study. Manning KE; Beresford-Webb JA; Aman LCS; Ring HA; Watson PC; Porges SW; Oliver C; Jennings SR; Holland AJ PLoS One; 2019; 14(12):e0223750. PubMed ID: 31794560 [TBL] [Abstract][Full Text] [Related]
12. Reduced gamma-aminobutyric acid is associated with emotional and behavioral problems in Prader-Willi syndrome. Rice LJ; Lagopoulos J; Brammer M; Einfeld SL Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1041-1048. PubMed ID: 27338833 [TBL] [Abstract][Full Text] [Related]
13. t-VNS to treat disorders of behaviour in Prader-Willi Syndrome and in people with other neurodevelopmental conditions. Holland A; Manning K Auton Neurosci; 2022 May; 239():102955. PubMed ID: 35219158 [TBL] [Abstract][Full Text] [Related]
14. Urinary incontinence in persons with Prader-Willi Syndrome. Von Gontard A; Didden R; Sinnema M; Curfs L BJU Int; 2010 Dec; 106(11):1758-62. PubMed ID: 20575983 [TBL] [Abstract][Full Text] [Related]
15. The relationship between specific cognitive impairment and behaviour in Prader-Willi syndrome. Woodcock KA; Oliver C; Humphreys GW J Intellect Disabil Res; 2011 Feb; 55(2):152-71. PubMed ID: 21199046 [TBL] [Abstract][Full Text] [Related]
16. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. Stein DJ; Keating J; Zar HJ; Hollander E J Neuropsychiatry Clin Neurosci; 1994; 6(1):23-9. PubMed ID: 8148633 [TBL] [Abstract][Full Text] [Related]
17. Suicidality in individuals with Prader-Willi syndrome: a review of registry survey data. Peleggi A; Bohonowych J; Strong TV; Schwartz L; Kim SJ BMC Psychiatry; 2021 Sep; 21(1):438. PubMed ID: 34488710 [TBL] [Abstract][Full Text] [Related]
18. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome. Holland AJ; Whittington JE; Butler J; Webb T; Boer H; Clarke D Psychol Med; 2003 Jan; 33(1):141-53. PubMed ID: 12537045 [TBL] [Abstract][Full Text] [Related]
19. Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling. Tsai JH; Scheimann AO; McCandless SE; Strong TV; Bridges JFP J Med Econ; 2018 Dec; 21(12):1230-1237. PubMed ID: 30256699 [TBL] [Abstract][Full Text] [Related]
20. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome. Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]